At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Impact of a Volumetric Image Method for Confirming Tumor Coverage With Ablation on Patients With Malignant Liver Lesions (COVER-ALL)
In Brief
A Phase 2 clinical trial evaluating Ablation Therapy, Image-Guided Therapy, and 2 other interventions for Malignant Liver Neoplasm. Active but no longer recruiting, targeting 107 participants across 1 site.
Detailed Summary
This phase II trial studies how well software-aided imaging works in confirming tumor coverage with ablation (the removal or destruction of a body part or tissue or its function) on patients with liver tumors. The current standard for targeting tumor cells and evaluating the outcome of a liver ablation procedure is a visual inspection of the pre- and post-procedure computed tomography (CT) scans. Software-aided imaging systems, such as Morfeus, may help to improve the accuracy and effectiveness of liver ablation.
Study Details
Timeline
Interventions
Undergo standard of care ablation
Undergo software-aided imaging (Morfeus)
Ancillary studies
Ancillary studies